| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/13/2011 | CN102014950A Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof |
| 04/13/2011 | CN102014949A Vascular aging inhibitor and anti-aging formulation |
| 04/13/2011 | CN102014948A Modulation of adenoviral tropism |
| 04/13/2011 | CN102014947A Leucine-rich peptide compositions and methods for isolation |
| 04/13/2011 | CN102014918A Pharmaceutical compositions prepared by trace precipitation |
| 04/13/2011 | CN102014880A Therapeutic calcium phosphate particles and methods of making and using same |
| 04/13/2011 | CN102014657A Soybean protein material for patients with renal disease and foods made from the same |
| 04/13/2011 | CN102010473A Recombinant oxyntomodulin (OXM) fusion protein, and preparation and application thereof |
| 04/13/2011 | CN102010471A Interleukin-10 antibodies |
| 04/13/2011 | CN102010460A Tea seed polypeptide and preparation method thereof |
| 04/13/2011 | CN102010425A 1,4-disulfide-7-azaspiro [4,4] nonane-8-carboxylic acid derivative histone deacetylase inhibitor and application thereof |
| 04/13/2011 | CN102008724A Method and reagent for inhibiting hepatocellular carcinoma |
| 04/13/2011 | CN102008718A Application of SIRT (Silent Mating Type Information Regulation 2 Homolog 1) to prepare medicine used for regulating down the expression of cyclin D1 |
| 04/13/2011 | CN102008717A Application of fusion protein PTD-SOD (protein transduction domain-superoxide dismutase) in preparing product for accelerating wound healing and product for accelerating wound healing |
| 04/13/2011 | CN102008716A Application of beta-interferon to medicament making |
| 04/13/2011 | CN102008715A Antitumor MA-TNF alpha medicine composition and application thereof |
| 04/13/2011 | CN102008714A Ointment for promoting rapid healing of scabby chilblain |
| 04/13/2011 | CN102008713A Ciclosporin A proliposome, pharmaceutical composition and preparation method thereof |
| 04/13/2011 | CN102008712A Trandolapril-containing compound preparation for curing hypertension |
| 04/13/2011 | CN102008711A Compound preparation containing enalapril for treating hypertension |
| 04/13/2011 | CN102008710A Lisinopril-containing compound preparation for treating hypertension |
| 04/13/2011 | CN102008709A Moexipril-contained compound preparation for treating hypertension |
| 04/13/2011 | CN102008708A Ramipril-contained compound preparation for treating hypertension |
| 04/13/2011 | CN102008707A Quinapril-contained compound preparation for treating hypertension |
| 04/13/2011 | CN102008628A Medicament for treating female genital tract virus infection and preparation method of sustained-release preparation of medicament |
| 04/13/2011 | CN102008455A Freeze-dried powder preparation for curing bovine mastitis |
| 04/13/2011 | CN102008436A Nocathiacin antibiotic medicament composition containing emulsifying agent |
| 04/13/2011 | CN102007873A Intensive artificial propagation method for Myxocyprinus asiaticus |
| 04/13/2011 | CN101611061B Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof |
| 04/13/2011 | CN101057966B Liposome nanometer carrier situ gel preparation used for eye epidermal growth factor |
| 04/13/2011 | CN101048170B Analgesic peptide like compounds stemed from rattlesnake crotalus durissus terrificus snake wenom, their application, compositions, preparation and purification method |
| 04/12/2011 | US7923548 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 04/12/2011 | US7923547 for antisense therapy |
| 04/12/2011 | US7923545 Caterpiller gene family |
| 04/12/2011 | US7923543 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 04/12/2011 | US7923535 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins |
| 04/12/2011 | US7923534 Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 |
| 04/12/2011 | US7923533 Methods for arbitrary peptide synthesis |
| 04/12/2011 | US7923532 Oligopeptide for use in prevention and treatment of gluten allergies |
| 04/12/2011 | US7923436 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/12/2011 | US7923433 Activity-based probes and methods of their preparation and use |
| 04/12/2011 | US7923432 Implant depots to deliver growth factors to treat avascular necrosis |
| 04/12/2011 | US7923431 Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| 04/12/2011 | US7923430 Methods for producing modified glycoproteins |
| 04/12/2011 | US7923429 Treatment for CD5+ B cell lymphoma |
| 04/12/2011 | US7923244 Artificial cartilage tissue and production method thereof |
| 04/12/2011 | US7923232 Hydrolase for use in enhancing digestibility and nutrient quality of animal feeds |
| 04/12/2011 | US7923216 In vivo modulation of neuronal transport |
| 04/12/2011 | US7923215 Involves immunizing female mice and based on specific recognition of the glatiramer acetate by T cells; determining if batch of glatiramer acetate is acceptable for drug use; quality control |
| 04/12/2011 | US7923208 Using presence of variation in Zcytor16 gene sequences as evaluative tool in diagnosis of cell proliferative disorders |
| 04/12/2011 | US7923045 Compositions for alleviating inflammation and oxidative stress in a mammal |
| 04/12/2011 | US7923031 Haemostatic sprays and compositions |
| 04/12/2011 | US7923025 Pharmaceutical composition for oral use with improved absorption |
| 04/12/2011 | US7923016 Engineered CXCL12 α locked dimer polypeptide |
| 04/12/2011 | US7923015 Methods for direct visualization of active synapses |
| 04/12/2011 | US7923008 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab |
| 04/12/2011 | US7923004 4-ethynyl pyrazole derivative compounds and methods for treatment of HCV |
| 04/12/2011 | US7922999 Administration of growth factors for the treatment of CNS disorders |
| 04/12/2011 | CA2460867C Nanoparticulate insulin formulations |
| 04/12/2011 | CA2456172C Kidney-specific urate transporter and uses thereof |
| 04/12/2011 | CA2434060C Preparation of a therapeutic composition |
| 04/12/2011 | CA2400908C Fusion protein having enhanced in vivo erythropoietin activity |
| 04/12/2011 | CA2396542C Composition promoting lacrimal secretion |
| 04/12/2011 | CA2388363C Dna polymerase lambda and uses thereof |
| 04/12/2011 | CA2354153C Compounds and methods for modulating activation of nf-.kappa.b |
| 04/12/2011 | CA2311409C Treatment with anti-erbb2 antibodies |
| 04/12/2011 | CA2277365C Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| 04/12/2011 | CA2050318C Endothelial cell growth factor, methods of isolation and expression |
| 04/12/2011 | CA1341612C Human tissue plasminogen activator variants and processes |
| 04/12/2011 | CA1341611C Interleukin-1 receptors |
| 04/07/2011 | WO2011041770A1 Compositions and methods for enhancing coagulation factor viii function |
| 04/07/2011 | WO2011041551A1 Therapeutic antiviral peptides |
| 04/07/2011 | WO2011041494A1 Tex14 peptides as novel antitumor agents |
| 04/07/2011 | WO2011041490A1 Peptides for inducing heterosubtypic influenza t cell responses |
| 04/07/2011 | WO2011041483A2 Use of botulinum neurotoxin to treat substance addictions |
| 04/07/2011 | WO2011041385A2 Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis |
| 04/07/2011 | WO2011041325A2 Methods and compositions for the treatment of viral disorders |
| 04/07/2011 | WO2011040954A2 Tp53 gene expression and uses thereof |
| 04/07/2011 | WO2011040888A1 A biodegradable composition or combination and uses thereof |
| 04/07/2011 | WO2011040823A1 Synthetic myostatin peptide antagonists |
| 04/07/2011 | WO2011040654A1 Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same |
| 04/07/2011 | WO2011040651A1 Therapeutic agent for atopic dermatitis |
| 04/07/2011 | WO2011040597A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same |
| 04/07/2011 | WO2011040564A1 Ophthalmic agent comprising specific peptide compound as active ingredient |
| 04/07/2011 | WO2011040052A1 Therapeutic agent for atopic dermatitis |
| 04/07/2011 | WO2011039999A1 Composition having lipolysis-promoting effect |
| 04/07/2011 | WO2011039507A1 T-cell receptor capable of recognising an antigen from cytomegalovirus |
| 04/07/2011 | WO2011039382A1 Antibacterial polypeptides and use thereof |
| 04/07/2011 | WO2011039282A1 Means and methods for treating ischemic conditions |
| 04/07/2011 | WO2011039171A1 Vasoactive peptide and derivatives thereof |
| 04/07/2011 | WO2011038901A1 Improved method for treatment of patients with cystic fibrosis |
| 04/07/2011 | WO2011038754A1 Oral care compositions containing human recombinant interleukin-1 |
| 04/07/2011 | WO2011038689A1 Novel human cytokine vstm1-v2 and use thereof |
| 04/07/2011 | WO2011038537A1 Methods and kits for the prediction, prevention and treatment of septicemia and septic shock |
| 04/07/2011 | WO2011038467A1 Method of treatment of philadelphia chromosome positive leukaemia |
| 04/07/2011 | WO2011038451A1 Therapy and prevention of problem drinking |
| 04/07/2011 | WO2011014680A3 Gastric inhibitory peptide variants and their uses |
| 04/07/2011 | WO2011013097A3 Polymer particles and uses thereof |
| 04/07/2011 | WO2011011072A3 Analogues of insulin-like growth factor-1 (igf-1) having amino acid substitution at position 59 |
| 04/07/2011 | WO2010149172A3 SYSTEMIC PRO-HEMOSTATIC EFFECT OF CLOTTING FACTORS IN COMBINATION WITH SYMPATHICOMIMETICS WITH AGONISTIC EFFECTS ON α-ADRENERGIC AND/OR β-ADRENERGIC RECEPTORS OF THE SYMPATHETIC NERVOUS SYSTEM, RELATED TO IMPROVED CLOT STRENGTH. |